Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma

Lung adenocarcinomas have diverse genetic and morphological backgrounds and are usually classified according to their distinct oncogenic mutations (or so-called driver mutations) and histological subtypes (the de novo classification proposed by the International Association for the Study of Lung Can...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	OncoTargets and therapy 2014-01, Vol.7, p.1423-1437
Hauptverfasser:	Hu, Haichuan, Pan, Yunjian, Li, Yuan, Wang, Lei, Wang, Rui, Zhang, Yang, Li, Hang, Ye, Ting, Zhang, Yiliang, Luo, Xiaoyang, Shao, Longlong, Sun, Zhengliang, Cai, Deng, Xu, Jie, Lu, Qiong, Deng, Youjia, Shen, Lei, Ji, Hongbin, Sun, Yihua, Chen, Haiquan
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Care and treatment Chemotherapy Crizotinib Diagnosis IASLC/ATS/ERS classification Lung cancer molecular testing oncogenic mutation Original Research personalized treatment prognosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!